Cas 1433716-89-2,N<sub>1</sub>-(3-4-[([5-(tert-butyl)-3-isoxazolyl]aminocarbonyl)amino]-3-methylphenyl-1H-5-pyrazolyl)-4-(2-morpholinoethoxy)benzamide

1433716-89-2

Post Buying Request

Basic information

Product Name: N₁-(3-4-[([5-(tert-butyl)-3-isoxazolyl]aminocarbonyl)amino]-3-methylphenyl-1H-5-pyrazolyl)-4-(2-morpholinoethoxy)benzamide
Synonyms:
CAS NO:1433716-89-2
Molecular Formula:
Molecular Weight: 587.679
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N₁-(3-4-[([5-(tert-butyl)-3-isoxazolyl]aminocarbonyl)amino]-3-methylphenyl-1H-5-pyrazolyl)-4-(2-morpholinoethoxy)benzamide(CAS DataBase Reference)
NIST Chemistry Reference: N₁-(3-4-[([5-(tert-butyl)-3-isoxazolyl]aminocarbonyl)amino]-3-methylphenyl-1H-5-pyrazolyl)-4-(2-morpholinoethoxy)benzamide(1433716-89-2)
EPA Substance Registry System: N₁-(3-4-[([5-(tert-butyl)-3-isoxazolyl]aminocarbonyl)amino]-3-methylphenyl-1H-5-pyrazolyl)-4-(2-morpholinoethoxy)benzamide(1433716-89-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1433716-89-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1433716-89-2 Suppliers

Recommended suppliers

1433716-89-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1433716-89-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,3,7,1 and 6 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1433716-89:
(9*1)+(8*4)+(7*3)+(6*3)+(5*7)+(4*1)+(3*6)+(2*8)+(1*9)=162
162 % 10 = 2
So 1433716-89-2 is a valid CAS Registry Number.

1433716-89-2Upstream product

1433716-89-2Downstream Products

1433716-89-2Relevant academic research and scientific papers

Pyrazolylamine Derivatives Reveal the Conformational Switching between Type i and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK)

Tu, Chih-Hsiang,Lin, Wen-Hsing,Peng, Yi-Hui,Hsu, Tsu,Wu, Jian-Sung,Chang, Chun-Yu,Lu, Cheng-Tai,Lyu, Ping-Chiang,Shih, Chuan,Jiaang, Weir-Torn,Wu, Su-Ying

, p. 3906 - 3919 (2016/05/24)

Most anaplastic lymphoma kinase (ALK) inhibitors adopt a type I binding mode, but only limited type II ALK structural studies are available. Herein, we present the structure of ALK in complex with N1-(3-4-[([5-(tert-butyl)-3-isoxazolyl]aminocarbonyl)amino

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1433716-89-2